customs policy
Hier finden Sie alle Informationen zum Thema customs policy.
Bayer Pharma has six „blockbuster candidates“ at the start
Stefan Oelrich, Member of Bayer's Board of Management and Head of the Pharmaceuticals Division, is confident about the development pipeline. As one important patent expires, he points to a range of new products that will generate big sales.
„Now is the time for action“
Lanxess CEO Matthias Zachert views a reduction in bureaucracy and a pragmatic energy policy as two crucial issues for the new German government. He would like to see the Corporate Sustainability Reporting Directive scrapped – without a replacement.